Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Fissolo N, Pignolet B, Brassat D, Comabella M, et al. Reply: MMP-9 as a biomarker of PML development in MS patients receiving Natalizumab. Ann Neurol 2017 Sep 4. doi: 10.1002/ana.25039.
PMID: 28869673


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016